This highlights a complex and critical area of research that requires further exploration to understand the differential roles and underlying mechanisms of CD4+ and CD8+ CXCL13+ T cells, especially those with varying levels of exhaustion and their interactions with other tumor-infiltrating T cells in response to ICB treatments. This evidence concerns the gene CD4 and neoplasm.